Science Shop
Advertisement
FDA approves breakthrough gene therapies
In a groundbreaking development, the first-ever gene-editing drug for a genetic disease has been approved in the United States. Developed by Vertex Pharmaceuticals and CRISPR
UK Approves CRISPR/Cas Drug Casgevy for Blood Disorders
The UK’s MHRA has greenlit Casgevy, a CRISPR/Cas gene-editing drug, for treating blood disorders. This groundbreaking approval offers hope to patients aged twelve and above
German Ethics Council approves CRISPR use
The German Ethics Council has released a statement indicating that they are no longer generally opposed to the use of the gene-editing tool, Crispr. However,
Stopping Coronavirus Spread with Crispr
A new treatment method has been developed by scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, using the enzyme Crispr/Cas13b
New gene scissors work on coronavirus.
A new gene-editing tool has been developed that can manipulate RNA-based structures, including the coronavirus. The previous CRISPR/Cas9 method was limited to DNA. The CRISPR/Cas9
Russian Scientist Continues Gene Experiments on Babies
A Russian scientist has announced his intention to conduct experiments on embryos using the CRISPR/Cas9 gene-editing tool, despite the known health risks. The Chinese scientist
Higher Mortality Risk in CRISPR-Edited Babies
The birth of genetically modified twins in China last year using CRISPR gene editing technology has caused a stir in the scientific community. While the
CRISPR Gene Editing Allowed in Russia
Russia is planning to revolutionize its commercial agriculture industry by using the controversial gene-editing tool CRISPR to develop 30 genetically modified organisms (GMOs) by 2027.
Crispr Cures HIV-Infected Mice
A new treatment method combining antiviral drugs and the gene-editing tool Crispr may soon offer hope for a cure for HIV-infected individuals. Researchers at the
